|
Company
Roster
|
Total
Insiders : |
31 |
|
|
Total
Direct Shares :
|
8,263,562 |
|
Total
Indirect Shares :
|
12,307,230 |
|
%
Held by Insiders:
|
87.81% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Kausz Annamaria T |
|
|
0 |
|
0 |
Hagelstein David A |
10% Owner |
2012-08-27 |
1,360,700 |
2012-08-27 |
450,552 |
Chioini Robert L |
Chairman, President and CEO, Director |
2017-12-15 |
2,549,907 |
2007-07-13 |
0 |
Paul Stuart M |
Chief Executive Officer, Director |
2019-09-04 |
330,056 |
2018-09-04 |
0 |
Smith Angus W. |
Chief Financial Officer |
2019-06-28 |
176,667 |
2018-11-28 |
0 |
Hoffman Marc L |
Chief Medical Officer |
2023-03-17 |
25,665 |
2023-03-17 |
0 |
Holt Kenneth L |
Director |
2017-03-16 |
12,630 |
2006-01-26 |
0 |
Bagley Patrick J |
Director |
2017-12-15 |
116,307 |
2017-12-15 |
112,200 |
Boyd Ronald D |
Director |
2017-12-15 |
42,678 |
2009-06-19 |
0 |
Colleran Lisa N |
Director |
2019-06-06 |
18,674 |
2019-06-06 |
0 |
Wolin Benjamin |
Director |
2019-06-06 |
27,710 |
2019-06-06 |
0 |
Smith Robin L |
Director |
2019-06-06 |
31,366 |
2017-03-21 |
0 |
Mclaughlin John Peter |
Director |
2021-06-17 |
136,974 |
2019-09-05 |
0 |
Ravich Mark H |
Director |
2023-05-23 |
303,319 |
2023-05-23 |
244,905 |
Smiley Andrea Heslin |
Director |
2023-05-23 |
118,316 |
2020-12-11 |
0 |
Nissenson Allen |
Director |
2023-05-23 |
124,203 |
2020-06-11 |
0 |
Cooper John G |
Director |
2023-05-23 |
155,594 |
2019-06-06 |
0 |
Radie Robert S |
Director |
2023-05-23 |
134,404 |
2020-03-31 |
0 |
Lau Joan |
Director |
2023-10-16 |
27,000 |
2023-10-16 |
0 |
Timmins Megan C. |
EVP, CLO and Secretary |
2024-03-17 |
75,378 |
2023-03-17 |
0 |
Strobeck Mark |
President and CEO, Director |
2024-03-17 |
149,364 |
2023-03-17 |
0 |
Kull David |
Principal Accounting Officer |
2019-04-25 |
13,270 |
2018-09-20 |
0 |
Alyssa Danielle Ravich 1991 Irrevocable Trust |
See Footnote 1 |
2017-05-19 |
314,750 |
2017-05-19 |
104,400 |
Curfman Matthew J. |
See Footnotes 1 and 2 |
2019-07-29 |
161,278 |
2020-12-21 |
5,294,077 |
Rbi Opportunities Fund Ii, Llc |
See Footnotes 1 and 2 |
2020-06-30 |
183,907 |
2020-06-30 |
6,101,096 |
Ellison Russell H |
See Remarks, Director |
2020-05-14 |
12,050 |
2020-01-09 |
0 |
Gupta Ajay |
Sr. VP & Chief Scientific Off. |
2020-04-26 |
574,700 |
|
0 |
Neri Jesse |
SVP, FINANCE |
2024-03-14 |
33,330 |
2024-03-14 |
0 |
Mcgarry Paul E |
SVP, Finance and CAO |
2023-03-17 |
28,515 |
2023-03-17 |
0 |
Klema Thomas E |
Vice President, CFO |
2017-12-15 |
671,492 |
2005-12-16 |
0 |
Pratt Raymond Dennis |
VP of Drug Development |
2020-04-26 |
353,358 |
2013-06-14 |
0 |
|